The role of autologous stem cell transplantation (ASCT) and the optimal timing of such
transplants in patients with follicular lymphoma (FL) remains contentious. We present a …

Although autologous stem cell transplantation (ASCT) can achieve durable responses in
eligible patients with follicular lymphoma (FL), long‐term follow‐up is needed to determine if …

High-dose chemotherapy supported by autologous stem cell transplantation (HDT/ASCT)
has contributed to modify the natural history of follicular lymphoma (FL); however, an overall …

Published studies have provided conflicting results regarding the curative potential of high
dose chemotherapy and autologous stem cell transplant (HDT/ASCT) for follicular …

Early relapsed or refractory follicular lymphoma (FL) warrants consolidation with
transplantation, though graft source modality remains controversial. We analysed the …

In advanced follicular lymphoma (FL), autologous stem cell transplant (ASCT) has been
studied extensively in an attempt to prolong remission duration and, possibly, achieve …

With the introduction of novel treatments paradigms to if or when to use transplantation
strategies for patients with follicular lymphoma have changed substantially. Autologous …

Thirty-five consecutive patients with follicular lymphoma (FL) receiving SCT at our institution
between January 2000 and December 2010 were included in this study. At the time of …

Treatment options for follicular lymphoma have expanded dramatically. The most important
relate to the introduction of monoclonal antibodies and the completion of important studies …

Background The impact of high-dose therapy and autologous stem cell transplantation
(ASCT) vs conventional-dose chemotherapy in the initial management of adults with …